Google just rewired the top of its AI organization, and the changes reach all the way to Demis Hassabis. According to The Verge AI, CEO Sundar Pichai announced on Wednesday that Hassabis is becoming chair of Google DeepMind and chief scientist at Alphabet, while stepping back from day-to-day command of the lab he’s led for years. This is a real structural shift, not a cosmetic title change, and it signals where Google wants its AI muscle pointed next.
Who’s moving where
The headline moves, as reported by The Verge AI:
- Demis Hassabis takes on the dual role of Google DeepMind chair and Alphabet chief scientist. He keeps running Isomorphic Labs, Alphabet’s AI drug-discovery outfit.
- Koray Kavukcuoglu, formerly DeepMind’s CTO, steps up to Google SVP of DeepMind and now reports directly to Pichai. He stays on as Google’s chief AI architect.
- Jeff Dean, DeepMind’s chief scientist and Google’s 30th employee, is leaving. So is Google Fellow Sanjay Ghemawat.
Dean and Ghemawat aren’t retiring. They’re starting a new AI-focused public benefit corporation called Discovery Loop, with Google signed on as a “founding investor,” Pichai says.
What Hassabis is really doing
Read the messaging and the direction is clear. Hassabis is leaning hard into health. “As you’ve heard me say many times, I’ve always believed the No. 1 application of AI should be to improve human health,” he told staff, per The Verge AI. “It’s time for AI to prove its unequivocal value to the world, and what better way to demonstrate that than to help finally cure diseases like cancer.”
He’s not walking away from strategy. Hassabis says he’ll “continue to work closely with Sundar on strategic and global AGI matters” and advise Kavukcuoglu and the other DeepMind leads. What stands out here is the trade: he’s swapping operational load for a bigger swing at drug discovery through Isomorphic Labs, while keeping a hand on the AGI roadmap.
Why this matters
DeepMind has been the crown jewel of Google’s AI push, the group behind Gemini and a long line of research wins. Putting Kavukcuoglu in the operator’s seat, reporting straight to Pichai, tightens the line between the lab and the company’s product and commercial priorities. That’s the status quo shifting. Research leadership and execution leadership are being pulled closer together at a moment when Google is racing OpenAI, Anthropic, and Meta on both models and shipping speed.
The Jeff Dean departure is its own story. Dean is one of the most influential engineers in modern computing, a name attached to the infrastructure that made large-scale machine learning possible. Losing him and Ghemawat to a startup would normally read as a blow. But Google investing in Discovery Loop looks less like a clean break and more like a hedge, keeping a stake in whatever the pair build next.
Discovery Loop’s stated aim, according to The Verge AI, is blunt: “we are building AI solutions that can automatically solve important problems in machine learning, science, and engineering.” That’s AI aimed at accelerating research itself, the same “AI for science” thesis Hassabis is chasing from inside Google. Two of Google’s most senior technical minds are now betting on that direction from opposite sides of the fence.
What to watch next
A few things worth tracking in the coming months:
- Kavukcuoglu’s fingerprints on Gemini. With a tighter reporting line to Pichai, expect DeepMind’s output to track Google’s product cadence more closely.
- Isomorphic Labs milestones. Hassabis is staking his reputation on curing disease. Watch for drug-candidate progress and pharma partnerships.
- Discovery Loop’s first moves. A Dean-and-Ghemawat company with Google money behind it will draw talent and attention fast.
Google is reorganizing its brightest people around two bets: keep winning the model race, and prove AI can deliver in science and medicine. The org chart just told you which way the company is leaning. For the full breakdown, check the original report at The Verge AI.